US 11466274
Modified gapmer oligonucleotides and methods of use
granted A61KA61K31/7088A61K31/7125
Quick answer
US patent 11466274 (Modified gapmer oligonucleotides and methods of use) held by Aligos Therapeutics, Inc. expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7088, A61K31/7125, A61P, A61P31/20